CIK 0001640266
- Accelerated filer
- Smaller reporting company
Voyager Therapeutics, Inc.
Sign in to watch- Ticker
- VYGR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-259-5340
- Business address
- 75 HAYDEN AVENUE, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-27 | Sah Dinah Ph.D. Chief Scientific Officer | Exercise or conversion | −4,063 | $11.83 | $48K | 154,311 |
| 2018-02-27 | Sah Dinah Ph.D. Chief Scientific Officer | Sale | −15,623 | $30.00 | $469K | 138,688 |
| 2018-02-27 | Sah Dinah Ph.D. Chief Scientific Officer | Exercise or conversion · Stock Option (Right to Buy) | −2,184 | 12,957 | ||
| 2018-02-27 | Sah Dinah Ph.D. Chief Scientific Officer | Exercise or conversion · Stock Option (Right to Buy) | −4,376 | 28,570 | ||
| 2018-02-27 | Sah Dinah Ph.D. Chief Scientific Officer | Exercise or conversion · Stock Option (Right to Buy) | −5,000 | 35,000 | ||
| 2018-02-27 | Sah Dinah Ph.D. Chief Scientific Officer | Exercise or conversion · Stock Option (Right to Buy) | −4,063 | 60,937 | ||
| 2018-02-12 | Ravina Bernard Chief Medical Officer | Sale | −2,451 | $18.24 | $45K | 4,902 |
| 2018-01-10 | Ravina Bernard Chief Medical Officer | Sale | −3,630 | $16.40 | $60K | 7,353 |
| 2017-12-11 | Ravina Bernard Chief Medical Officer | Sale | −5,490 | $13.63 | $75K | 10,983 |
| 2017-11-10 | Ravina Bernard Chief Medical Officer | Sale | −5,490 | $13.26 | $73K | 16,473 |
| 2017-10-10 | Ravina Bernard Chief Medical Officer | Sale | −10,980 | $20.33 | $223K | 21,963 |
| 2017-09-14 | Ottmer Matthew P. Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2017-09-11 | Ravina Bernard Chief Medical Officer | Sale | −10,980 | $14.30 | $157K | 32,943 |
| 2017-09-05 | Ravina Bernard Chief Medical Officer | Sale | −5,490 | $10.00 | $55K | 17,157 |
| 2017-07-20 | Ravina Bernard Chief Medical Officer | Sale | −5,490 | $10.00 | $55K | 49,413 |
| 2017-06-29 | LEVIN MARK J Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2017-06-29 | DIXON WENDY L Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2017-06-29 | Higgins Michael J Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2017-06-29 | GERAGHTY JAMES A Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2017-06-29 | KARSEN PERRY A Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 |
Page 17 of 19 · 368 trades